Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
6 hedge funds and large institutions have $541K invested in Bionano Genomics, Inc. Warrant in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
866% more capital invested
Capital invested by funds: $56K → $541K (+$485K)
20% more funds holding
Funds holding: 5 → 6 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$278K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$415 |
BNGOW Hedge Fund Activity: Q1 2020 in Review
6 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q1 2020, worth a combined $541K — up 866% from $56K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BNGOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $278K. The largest seller was Susquehanna International Group, cutting an estimated $14.2K.
- 6 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q1 2020, up from 5 in Q4 2019.
- Funds reported $541K of Bionano Genomics, Inc. Warrant stock for Q1 2020, up 866% quarter-over-quarter.
- 1 fund opened new Bionano Genomics, Inc. Warrant positions in Q1 2020 and 0 closed out, a net change of +1 holder.
- The largest Bionano Genomics, Inc. Warrant buyer in Q1 2020 was Alyeska Investment Group, an estimated $278K added.
- The largest Bionano Genomics, Inc. Warrant seller in Q1 2020 was Susquehanna International Group, an estimated $14.2K sold.
Based on aggregated 13F filings for Q1 2020.